Company Valuation: Dolby Laboratories, Inc.

Data adjusted to current consolidation scope
Fiscal Period: September 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 9,375 6,589 7,494 7,231 6,938 4,642 - -
Change - -29.72% 13.74% -3.51% -4.05% -33.1% - -
Enterprise Value (EV) 8,103 5,772 7,494 7,231 6,938 4,642 4,642 4,642
Change - -28.77% 29.85% -3.51% -4.05% -33.1% 0% 0%
P/E 31.1x 37.3x 38.2x 28.2x 27.6x 15.1x 13.4x 13.5x
PBR 3.6x 2.88x - - 2.65x 1.74x - -
PEG - -1x 2.9x 0.9x -10.61x 0.6x 1.1x -37x
Capitalization / Revenue 7.32x 5.26x 5.77x 5.68x 5.14x 3.3x 3.17x 3.01x
EV / Revenue 0x 0x 0x 0x 0x 3.3x 3.17x 3.01x
EV / EBITDA 0x 0x 0x 0x 0x 8.62x 8.18x 7.59x
EV / EBIT 0x 0x 0x 0x 0x 9.77x 13.7x 11.6x
EV / FCF 0x 0x 0x 0x 0x 13.6x 9.31x 8.59x
FCF Yield 4.2% 4.11% 4.49% 4.11% 6.28% 7.34% 10.7% 11.6%
Dividend per Share 2 0.91 1.02 1.11 - 1.32 - - -
Rate of return 0.98% 1.51% 1.42% - 1.82% - - -
EPS 2 2.97 1.81 2.05 2.69 2.62 3.25 3.653 3.64
Distribution rate 30.6% 56.4% 54.1% - 50.4% - - -
Net sales 1 1,281 1,254 1,300 1,274 1,349 1,406 1,462 1,541
EBITDA 1 550.2 420.6 463.9 460.1 496.3 538.6 567.5 611.9
EBIT 1 344.4 206.6 215.8 258.3 265 475 338.1 398.6
Net income 1 310.2 184.1 200.7 261.8 255 258.7 294.1 342.6
Net Debt -1,272 -817.6 - - - - - -
Reference price 2 92.47 67.46 78.36 75.84 72.39 49.07 49.07 49.07
Nbr of stocks (in thousands) 101,387 97,677 95,641 95,348 95,844 94,598 - -
Announcement Date 16/11/21 17/11/22 16/11/23 19/11/24 18/11/25 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
15.1x - - - 4.64B
-350.24x6.61x24.67x-.--% 24.25B
147.59x0.79x9.95x-.--% 7.09B
58.12x1.42x10.21x-.--% 3.38B
21.99x2.17x10.53x1.51% 1.57B
20.99x - - - 421M
-10.35x - - - 352M
Average -13.83x 2.75x 13.84x 0.38% 5.96B
Weighted average by Cap. -171.24x 4.79x 19.84x 0.07%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. DLB Stock
  4. Valuation Dolby Laboratories, Inc.